
Paolo A. Ascierto: I owe it every day to Giuseppe, to Carla, to Rosina, to Gabriele, to the many who are still part of that 50% who are less lucky
Quoting Paolo A. Ascierto, Director Department of Melanoma, Cancer Immunotherapy, Development Therapeutics at the National Cancer Institute IRCCS G. Pascale Foundation on LinkedIn:
“Giuseppe was 17 years old, he passed away around Christmas, and who ever forgets that Christmas, it was like losing a son, a brother, a father. Before Giuseppe there was Carla, today she would have been 58 years old. She was Adolfo’s sister, my friend met during the year of service in the Air Force, whose wedding I later witnessed and with whom I spent my life it intersects cyclically, as often happens in ancient feelings. Carla passwd away in 1999. Before that moment she made and gave me a crochet painting which is now in my department, on the first floor of the IRCCS Istituto Nazionale Tumori Fondazione G Pascale, Napoli, Italy. Rosina died very young. I tried to save her with the vaccine, the Cancer vax, for which we had so much hope. At the time I thought it could prove to be a cure that could, if not completely eradicate, at least block the tumor. Rosina always brought me tagliatelle when she came to visit and before dying her brother confided to me one day that she had had a thought for me even on her deathbed. Every time I eat tagliatelle I think of her. I still can’t mention Gabriele without my voice getting caught in my throat. He died in 2020 for a metastatic melanoma. He was 17 years old and he passed away within a few weeks. Gabriele is part of that 50 percent of patients that we still cannot save and for whom science can and must still do a lot.
To Gabriele, but more ultimately to all my patients who passed away, I dedicate these 30 years of my life at Pascale. It was October 28, 1993 when I was hired as medical director in this Institute. They have been 30 intense years. Thirty years of bitter defeats, but also of great personal and above all professional satisfaction, of travel around the world in desperate search of that drug which today saves, yes, I can say with pride “it saves”, the lives of 50% of patients suffering from melanoma. A percentage that still cannot be enough for us and for which I continue to work, together with my collaborators, with the same enthusiasm as when I joined Pascale. I owe it every day to Giuseppe, to Carla, to Rosina, to Gabriele, to the many who are still part of that 50% who are less lucky.”
Source: Paolo A. Ascierto/LinkedIn.
-
Dec 10, 2023, 17:20 | BlogDaniel Blanco: Day 1 of the 2023 St. Jude Global Alliance Convening
-
Dec 10, 2023, 16:59 | InsightYüksel Ürün: MFS continues to be a reliable predictor for overall survival
-
Dec 10, 2023, 16:53 | PositiveMatteo Lambertini: December 7, 2023 …a day to remember
-
Dec 10, 2023, 12:45 | BlogSIOP: Worldwide Candle Lighting Day is a celebration of solidarity and memory
-
Dec 10, 2023, 12:20 | BlogTedros Adhanom Ghebreyesus: France plays a critical role in global health
-
Dec 10, 2023, 18:12The Cancer Research Interns (CRI) Summer Program is now accepting applications! - Train at NCI
-
Dec 10, 2023, 18:08Apply for the Basic Research in Cancer Health Disparities Program - NCI Center to Reduce Cancer Health Disparities (CRCHD)
-
Dec 10, 2023, 18:01Giselle Sholler: Our research that led to the FDA-Oncologic Drugs Advisory Committee 70% approval for moving Difluoromethylornithine forward
-
Dec 10, 2023, 16:59Yüksel Ürün: MFS continues to be a reliable predictor for overall survival
-
Dec 10, 2023, 12:03Eleonora Teplinsky: The POSITIVE Trial SABCS23 updates are so important to help with oncofertility counseling
-
Dec 10, 2023, 16:53Matteo Lambertini: December 7, 2023 …a day to remember
-
Dec 8, 2023, 16:33Big thank you to Dr. Rucha Kiran Patil for sharing their experiences and learnings on writing abstracts and poster presentations - Novo Nordisk Haemophilia Foundation
-
Dec 6, 2023, 14:57Tracy Gosselin: Jennifer Petruno Receives DAISY Award for Extraordinary Nurses
-
Dec 3, 2023, 16:34Tedros Adhanom Ghebreyesus: Grateful to Namibia’s Prime Minister Saara Kuugongelwa-Amadhila for her commitment to health
-
Dec 2, 2023, 18:08100 Influential Celebrities in Oncology: The 2023 Edition – Part 5
-
Dec 10, 2023, 05:08Global Summit on War and Cancer: Agenda
-
Dec 4, 2023, 16:26SIOP 2023 by Numbers! - International Society of Paediatric Oncology
-
Dec 2, 2023, 16:43In our recent survey, nearly 1,700 ASCO members shared feedback on the ABIM MOC requirements - ASCO
-
Nov 28, 2023, 17:34The International Association of Cancer Registries annual conference - IARC
-
Nov 26, 2023, 18:05Submit your abstract by 13 February for ESMO-Breast-24 - ESMO
-
Dec 10, 2023, 17:39Dr. Salami is the winner of the American Urological Association’s prestigious Gold Cystoscope Award - YUO
-
Dec 10, 2023, 17:26Mark Awad was honored by GO2 for Lung Cancer at the 18th Annual Simply the Best Gala - Dana-Farber Cancer Institute
-
Dec 9, 2023, 17:00Wafik S. El-Deiry: Honored to share the news of my election as the Chair of the WIN Consortium in Personalized Cancer Medicine
-
Dec 8, 2023, 17:54Dana-Farber News congratulates Sara Tolaney on receiving the Susan G. Komen 2023 Rising Star Researcher Award
-
Dec 8, 2023, 17:35Timothy M. Pawlik: Excited to announce Samilia Obeng-Gyasi as THE inaugural Endowed Surgical Professor in Health Equity